Logo do repositório

Enzymatic production process of capric acid-rich structured lipids: Development of formulation as a new therapeutic approach

dc.contributor.authorMiotti, Rodney H. [UNESP]
dc.contributor.authordo Amaral, Stephanie R. [UNESP]
dc.contributor.authorFreitas, Amanda Noli [UNESP]
dc.contributor.authorBento, Heitor B.S. [UNESP]
dc.contributor.authorde Carvalho, Ana Karine F.
dc.contributor.authorPrimo, Fernando L. [UNESP]
dc.contributor.authorde Paula, Ariela V. [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.date.accessioned2025-04-29T18:36:28Z
dc.date.issued2024-02-01
dc.description.abstractThe present work reports an optimization of the synthesis of MLM-type (medium, long, medium) structured lipids (SL) through an acidolysis reaction of grape seed oil with capric acid catalyzed by Rhizopus oryzae lipase immobilized. At first, tests were carried out by preparing the biocatalysts using enzyme loadings (0.15 to 1 g of enzymatic powder) for each gram of support. Enzyme loading was used 0.3 g of enzymatic powder, and hydrolytic activity of 1860 ± 23.4 IU/g was reached. Optimized conditions determined by the Central Composite Rotatable Design (CCRD) revealed that the acidolysis reaction reached approximately 59 % incorporation degree (%ID) after 24 h, in addition to the fact that the biocatalyst could maintain the incorporation degree in five consecutive cycles. From this high incorporation degree, cell viability assays were performed with murine fibroblast cell lines and human cervical adenocarcinoma cell lines. Concerning the cytotoxicity assays, the concentration of MLM-SL to 1.75 and 2 % v/v were able to induce cell death in 56 % and 64 % of adenocarcinoma cells, respectively. Human cervical adenocarcinoma cells showed greater sensitivity to the induction of cell death when using emulsions with MLM-SL > 1.75 % v/v compared to emulsions with lower content indicating a potential for combating carcinogenic cells.en
dc.description.affiliationDepartment of Bioprocess Engineering and Biotechnology São Paulo State University (UNESP) School of Pharmaceutical Sciences, São Paulo
dc.description.affiliationDepartment of Basic and Environmental Sciences Engineering School of Lorena University of São Paulo
dc.description.affiliationUnespDepartment of Bioprocess Engineering and Biotechnology São Paulo State University (UNESP) School of Pharmaceutical Sciences, São Paulo
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipIdFAPESP: 2017/11482-7
dc.description.sponsorshipIdFAPESP: 2020/09592–1
dc.identifierhttp://dx.doi.org/10.1016/j.ijbiomac.2023.128641
dc.identifier.citationInternational Journal of Biological Macromolecules, v. 257.
dc.identifier.doi10.1016/j.ijbiomac.2023.128641
dc.identifier.issn1879-0003
dc.identifier.issn0141-8130
dc.identifier.scopus2-s2.0-85180455161
dc.identifier.urihttps://hdl.handle.net/11449/298210
dc.language.isoeng
dc.relation.ispartofInternational Journal of Biological Macromolecules
dc.sourceScopus
dc.subjectCapric acid
dc.subjectLipase
dc.subjectStructured lipids
dc.titleEnzymatic production process of capric acid-rich structured lipids: Development of formulation as a new therapeutic approachen
dc.typeArtigopt
dspace.entity.typePublication
relation.isOrgUnitOfPublication95697b0b-8977-4af6-88d5-c29c80b5ee92
relation.isOrgUnitOfPublication.latestForDiscovery95697b0b-8977-4af6-88d5-c29c80b5ee92
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Ciências Farmacêuticas, Araraquarapt

Arquivos